39 Wadhurst drive Boronia, VIC, 3155 AustraliaPharmSky Research is a contract research and drug development company located in Melbourne, Australia. Our product development team hold decades of experience in big pharma and drug delivery space. PharmSky specializes in drug development, complex formulations, analytical method development, stability testing, regulatory and clinical trial manufacturing. Claim up to 43.5% of your R&D expenditure with us through The Australian Government's Research and Development (R&D) Tax Incentive scheme. Enquire within for more information.

Cancer Therapeutics CRC Pty Ltd
4 Research Ave. Bundoora VIC 3083 AustraliaCancer Therapeutics focuses on developing high quality leads and preclinical small molecule drug candidates that target specific pathways related to the tumor microenvironment or growth.

70 Racecourse Road North Melbourne, VIC, 3051 AustraliaMicrosurfaces' manufacture unique polymer inserts enable dynamic live cell analysis of extended live cell imaging experiments. It is now possible to image single cells up to thousands of cells with single cell resolution for high content imaging and analysis applications in immunology, drug discovery and screening as well as embroid body formation. The versatility and flexibility of the microcell array inserts allow for unprecedented access to cellular events not possible before with live cells, increasing the quantity and quality of the data collected from a single live cell imaging experiment. The advantage of the microcell arrays means no more time consuming fixing based time course experiments. Extended imaging and tracking of sub-populations of cells or single cells over multiple generations is now possible resulting in more cells and more results in less time.

Unit 4, 17-19 Hi Tech Court Croydon South, Victoria 3136 AustraliaMicrogenetix offers microbiology services including bacterial and fungal identification.

Royal Children's Hospital Flemington Road Parkville , Victoria, 3052 AustraliaChildren experience disease differently to adults and the treatments that are needed for children are different too. That's why our research is crucial, so we can find the best way to prevent disease and treat children to give them the healthiest possible start to life. Our researchers work across three areas: in the lab to investigate why disease occurs, clinical research working beside doctors and nurses to influence diagnosis and treatment and broad community studies to understand how disease impacts children in the wider community.

27-31 Wright StreetMonash Institute of Medical Research offers its core facilities to offer flow cytometry, sequencing, high content screening, immunoassay, gene targeting, histology, and micro imaging services.

Croydon South, VIC, 3136 AustraliaMicrogenetix offers microbiology services including bacterial and fungal identification.

305 Grattan Street Melbourne , VIC, 3000 AustraliaThe Tissue bank is a member of the Victorian Cancer Biobank, providing researchers with ethically collected, high quality human tissue, blood and data samples for their investigative projects; it also supports clinical trials at Peter Mac by processing and storing blood and tissue specimens in accordance with trial-specific protocols. HUMAN TISSUE SAMPLES After consenting patients, Peter Mac’s Tissue bank takes annotated specimens of human tissue that are not required for pathological testing. These samples are then "snap frozen" to ensure that ice crystals do not distort the arrangement of cells, and formalin fixed and paraffin embedded (FFPE). The embedded tissue is then sliced into very thin sections. These samples are divided, labelled and grouped for use in research studies, classified by tumour type and subtype, and as cancerous or benign. MICROARRAYS The Tissue bank also prepares tissue microarrays (TMAs), by taking a core ("punching" a hole) through layers of a single FFPE tissue block, across many different sample blocks and combining the cores in one TMA block. Thin sections are then cut from this TMA block, allowing researchers to analyse for a particular gene expression from many different samples in a single experiment, quickly and efficiently. BLOOD SAMPLES Blood samples are collected from consenting donors and separated and stored as mononuclear cells, buffy coat, plasma and serum. The Tissue bank also extracts DNA from tissue and blood products, allowing researchers to look at DNA derived from tumour tissue to identify changes that occur in cancer. They can also look at germline DNA, from blood samples or normal tissue, to determine if a cancer is inherited or acquired.

801 Swanston St University of Melbourne VIC 3010, AustraliaUniversity of Melbourne focuses on research.

Melbourne, VIC AustraliaUniversity of Melbourne focuses on research.

305 Grattan Street Melbourne , VIC, 3000 AustraliaThe Bioinformatics Consulting Core (BCC) in the Cancer Research Division at Peter Mac provides a range of services and know-how for data analysis. BIOINFORMATICS CONSULTING CORE FACILITY The aim of BCC is to provide all levels of bioinformatics support to research laboratories within Peter Mac and, more broadly, within the Victorian Comprehensive Cancer Centre (VCCC). The team of bioinformaticians and postdoctoral scientists at BCC work alongside laboratory and clinical researchers and contribute to their experimental design, grant applications and the analysis and publication of genomic and transcriptomic data. Data types analysed by the core include whole-exome sequencing, targeted re-sequencing, RNA-sequencing, ChIP-sequencing, NanoString and various types of microarray data.

160 South Gippsland Highway Dandenong South, VIC, 3175 AustraliaFor over 30 years, SteriTech has supplied, managed, and maintained critical process equipment for the pharmaceutical industry in the Irish and UK markets. We proudly represent industry leaders Fedegari, Stilmas, Dara, and Olsa, Bonfiglioli and offer cutting-edge equipment solutions, process optimisation, validation, and lifecycle support services.

75 Commercial Road, Melbourne, Victoria 3004, AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.

PO Box 6492, Melbourne Victoria 3004, AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.

5 Commercial Road Melbourne, Victoria, 3004 AustraliaBaker IDI is one of the few institutes in the world where the work of staff spans benchtop to bedside and where research is dedicated to tackling the deadly trio of diseases: cardiovascular disease, diabetes and obesity. The Institute’s science strategy reflects the breadth of the areas that we work across in order to enhance the diagnosis, prevention and treatment of chronic disease. In order to ensure that our work is relevant to the communities in which we operate, the strategy reflects a strong focus on collaboration and translation, tackling big-picture health questions and working with investors, industry and government to drive better health. Our strategies To retain the Institute's traditional independence, flexibility, agility and specialised focus. To collaborate extensively with hospitals, universities and other research institutes locally and around the world. Baker IDI's research activities will continue to be driven by an intention to contribute to a global reduction in death and disability from cardiovascular disease, diabetes and associated metabolic diseases. The Institute's output will be self-evidently translational through the mechanisms of technology transfer and commercialisation, involvement in and support of the direct delivery of clinical services, and influencing policy and guidelines. Baker IDI will remain a pre-eminent contributor to Australian, regional and global academic output in medical research through traditional peer-reviewed mechanisms and metrics. The Institute will develop the capacity to fund, manage and support basic and clinical research and research translation outside the confines of peer-reviewed grant and publication processes. Whilst much research will continue to be investigator-driven, specific programs of research will be thematically consistent with the overall disease mitigation objectives in the Institute's mission. Baker IDI will have an open, flexible and collaborative culture with mutual recognition and respect of the contributions made within the organisation across all disciplines.

PO Box 851 Eltham VIC 3095 AustraliaAgricultural and veterinary chemicals registration and regulatory consulting

305 Grattan Street Melbourne , VIC, 3000 AustraliaThe Centre for Advanced Histology and Microscopy (CAHM) underpins a multitude of cancer research projects and houses four core platforms: Histology. Optical Microscopy, which houses a suite of state-of-the-art high-end optical microscopes including laser scanning confocal microscopes, a multi-modal super resolution microscope and multiphoton microscope, a a dual laser multiphoton microscope, and a laser capture microscope. Electron Microscopy, inclusive of both transmission and scanning electron microscopy Image Analysis. Importantly, researchers utilising CAHM receive support, training, and advice from expert technical scientists. In addition to being head of CAHM, Associate Professor Sarah Ellis leads her own independently funded research group, investigating the role of the polarity proteins, Scribble and Par3, in the onset and progression of leukemia. RESEARCH FOCUS Polarity proteins control a multitude of cellular processes including apical-basal cell polarity, asymmetric cell division, planar cell polarity, migration, cell proliferation, differentiation, and apoptosis. We are investigating the role of two different polarity proteins, Scribble and Par3, in steady-state blood production (haematopoiesis) and leukaemia. Recent studies have revealed Scribble and Par3 act in a context dependent manner as either tumour suppressors or tumour promoters in various epithelial cancers but the roles of these proteins in blood production and blood malignancies are largely unknown. Using inducible Scribble and Par3 knockout mouse models in conjunction with mouse models that mimic human leukaemia, we are investigating how loss of these proteins impacts on the proliferation and differentiation of haematopoietic stem and progenitor cells as well as their more differentiated progeny. Our studies will provide a detailed understanding of the role of Scribble and Par3 in both normal and aberrant blood production and will advance the current knowledge on the molecular mechanisms driving the onset and severity of leukemia. Understanding how these proteins impact on leukemia has the potential to lead to novel therapeutic targets.

27 Healey Road Dandenong, VICTORIA 3175 AUSTRALIASypharma manufactures and markets sterile and non-sterile products under a range of brands.

801 Swanston StUniversity of Melbourne Tolcos Lab focuses on research in perinatal brain injury.

Parkville, VIC, 3052 AustraliaSynkinase offers kinase inhibitors, building blocks, and custom synthesis services.

1019 Mountain Highway Boronia Victoria 3155 AustraliaBaxter Laboratories specializes in the development and manufacturing of skin care, sunscreen and topical pharmaceutical/dermatological products.

Suite 6202 135 A'beckett Street Melbourne, VIC, 3103 Australia

VIC AustraliaMonash Animal Services offers animal models and breeding services as well as antibody production and X-Ray imaging services.

University of Melbourne Chemistry Distribution Centre, Building 153, Monash Road via Gate 4 off Swanston Street Melbourne, Victoria, 3103 AustraliaMessenger Bio offers custom mRNA & LNP encapsulation services for preclinical studies. We've worked with 100’s of customers, from those with specific request to those who need a guiding hand and advice along the way. We perform sequence optimisation (coding and non-coding regions), addition of tags, promoters and can encapsulate your mRNA with desired lipids, proteins or other molecules. We can add targeting moieties to LNPs and we also provide in-vitro testing of targets to speed up the evaluation process. Contact us at hello@messenger.bio to learn more.

Building 21 885 Mountain Highway Bayswater Victoria, 3153 AustraliaKCAS Bio has offered GLP and non-regulated Bioanalytical, Biomarker, Flow Cytometry, and PCR support for the last 40 years in studies from preclinical through clinical with a strong record of regulatory approvals. We offer international services with facilities in the US and in Europe. Our services include the following clinical and preclinical support in a wide variety of species and matrices: - LC-MS/MS and HRMS - Flow Cytometry - ddPCR and qPCR - Hybrid LC-MS/MS - Ligand Binding Assays – PK and ADA - Soluble Biomarkers - Biospecimen Management - Sample Kitting Services (clinical and non-clinical) - Dose Solution Analysis for preclinical studies We pride ourselves on our ability to be flexible and consultative in our approach to solutions. Our focus on quick initiation of projects allows us to meet your timing needs. Please contact us to see how we can support your drug development programs.

305 Grattan Street Melbourne , VIC, 3000 AustraliaWHAT IS BACT? Based at Peter Mac for over 40 years, the Centre for Biostatistics and Clinical Trials (BaCT) provides a full range of services to clinical trials to facilitate the advancement of patient treatments and improved outcomes for cancer patients. BaCT supports diverse clinical trials: Investigator-initiated studies Company sponsored trials Collaborative group studies WHY COLLABORATE WITH BACT? Established relationships with major oncology units across Australia and New Zealand Collaboration throughout all phases of clinical trial Efficient and low cost data capture strategies Clinical trial and data management for optimization of protocol delivery Promotes and fosters optimal integrity and highest quality across clinical trial initiatives Extensive experience with collaborative groups National leaders in the co ordination of oncology clinical research Support for grant applications SERVICES Study Design & Development Expert advice on trial design from clinical, regulatory and statistical perspectives Design of study protocols Collaborative protocol preparation Advice regarding all areas of study conduct Customised services for biostatistical and clinical trial needs Data Management eCRF design and development (21CFR Part11 compliant) Integrated Web Response Systems (IWRS) Consistency checks and data validation Data processing Medical coding User training Study Start-Up Site preparations and initiation Trial Master File (TMF) preparation & management Protocol specific training Essential document preparation including master, site-specific Patient Informed Consent Forms Statistics Study design and protocol development Interim and final statistical analyses including advanced statistical modelling Development of statistical analysis plan (SAP) Safety Review Committees Statistical reporting Randomisation and treatment allocation including restricted and adaptive methods Sample size and power calculations Assistance with manuscripts Clinical Trial Management Study progress reporting Source data verification Protocol amendments Risk management Site management Vendor management Safety reporting management Trial management committees

305 Grattan Street Melbourne , VIC, 3000 AustraliaPeter Mac’s excellence in cell and tissue manufacture led to the commercialisation and expansion of this business – Cell Therapies – as a manufacturer of cellular therapeutics. In the VCCC building, Cell Therapies now operates the leading facility of its kind in Australia and the Asia-Pacific region. Recent breakthroughs in gene therapy, immunotherapy, stem cell therapy and tissue regeneration have made Cell Therapies an internationally important business. It ensures that new therapies developed overseas can reach Australian patients and that cellular therapies developed by breakthrough Australian research can be produced to GMP grade quality and reach global markets. Cell Therapies manufactures human cells as therapeutic agents. There are two broad categories of product: Autologous: using the patient’s own cells, manipulated and returned to them. Allogeneic: using a donor’s cells, banked, manipulated and distributed to (potentially) many patients.

305 Grattan Street Melbourne , VIC, 3000 AustraliaClinical trials are central to Peter Mac’s commitment to finding more effective cancer treatments and improving care for people with cancer, their families and carers. ABOUT CLINICAL TRIALS SUPPORT In order to run more than 200 clinical trials every year, Peter Mac has a comprehensive network of clinical trials support in place, bringing together laboratory researchers, medical, surgical and radiation oncologists, many of whom are clinician-researchers, pathologists, pharmacists, geneticists and clinical trials nurses. Clinical trials at Peter Mac are coordinated through a dedicated clinical trials unit, whose members liaise with trial sponsors to manage ethical approval and enforce regulations, and assist in drug administration, patient monitoring and care, and the collection of trial-specific biological samples. The Centre for Biostatistics and Clinical Trials (BaCT) provides and coordinates trial management, data management and statistical support. Peter Mac’s Pharmacy team evaluates new medicines and supports and promotes their safe and ethical use, ensuring the use of new medicines complies with relevant legislative acts, standards and guidelines. They support the safety and welfare of participants, including the protection of their rights, confidentiality and privacy. Pharmacy also maintains trial-specific preparation and dispensing records, and provides information about drug interactions and contraindications to participants and their carers, medical and nursing staff, and other pharmacists. Peter Mac’s Technology Transfer Office facilitates smooth interaction between researchers and industry. Many of our clinicians and researchers are members of Cancer Trials Australia, which streamline trials of new approaches to treating cancer, including fast-tracking all studies, including first-in-human trials, through an efficient, consolidated ethical approval process. Most important of all, Peter Mac patients are at the heart of all clinical trials. As well as benefiting from access to new and improved treatments, patients are also able to directly contribute to research by participating in research studies; by sharing their thoughts, or donating blood or cancer tissue, patients can potentially help to improve outcomes for other people with cancer, everywhere. View participating in clinical research for the referral process to join a trial at Peter Mac. Peter Mac supports and recommends all patients considering participation in appropriate, ethically approved clinical trials.

305 Grattan Street Melbourne , VIC, 3000 AustraliaThe Victorian Centre for Functional Genomics (VCFG) at Peter Mac offers biomedical researchers Australia-wide the ability to perform novel discovery-based functional interrogation all genes in the genome, or selected boutique collections using multiple platforms including CRISPR/cas9, small interfering RNA (siRNA), micro RNA (miRNA) and long non-coding RNA (lncRNA) and short hairpin RNA (shRNA). The VCFG facilitates small scale drug screens using commercially available compounds or your own source. The VCFG has established a Reverse Phase Protein Array platform, another high throughput discovery technology that allows for rapid quantitation of the expression of native and phospho-specific protein isoforms in very small sample populations. The VCFG also offers Short Tandem Repeat (STR) profiling for cell line authentication.

Victoria, 3800 AustraliaMonash Antibody Technologies Facility (MATF) offers custom antibody production services.

11 Stanley Street Wodonga, VIC, 3690 AustraliaLa Trobe Animal Research and Teaching Facility provide housing, husbandry and technical resources supporting the use of a diverse range of animals involved in research and teaching activities at the University. We provide/support: Technical equipment and expertise to facilitate research and teaching involving animals Training and competency assessment programs in animal skills Animal housing, monitoring and husbandry across a range of species including rodent, avian, reptile and native IVC and conventional laboratory rodent housing facilities Specified Pathogen Free (SPF) housing for mice Veterinary services Behavioural Testing suites for rats and mice IVIS imaging equipment Radsource cell/animal irradiator Dedicated rodent surgical suites Expertise to support Animal Ethics Committee and Institutional Biosafety Committee requirements Best practice in animal welfare Compliance with regulatory requirements.

Union Building, Level 3, Room 313 Wodonga, Victoria, 3689 AustraliaLa Trobe Animal Research and Teaching Facility provide housing, husbandry and technical resources supporting the use of a diverse range of animals involved in research and teaching activities at the University. We provide/support: Technical equipment and expertise to facilitate research and teaching involving animals Training and competency assessment programs in animal skills Animal housing, monitoring and husbandry across a range of species including rodent, avian, reptile and native IVC and conventional laboratory rodent housing facilities Specified Pathogen Free (SPF) housing for mice Veterinary services Behavioural Testing suites for rats and mice IVIS imaging equipment Radsource cell/animal irradiator Dedicated rodent surgical suites Expertise to support Animal Ethics Committee and Institutional Biosafety Committee requirements Best practice in animal welfare Compliance with regulatory requirements.

, Bundoora, VIC 3086, AULa Trobe University participates in a number of collaborative research centres and joint ventures with other research organisations, industry and government bodies. Pursuant to the Strategic Plan, the University will deepen its research capacity by supporting a number of research institutes that will provide an opportunity for a significant number of academic staff from more than one discipline area to focus their research effort on a common field of enquiry. The expectation is that all institutes will develop a strong track record of external research funding.

John Scott Meeting House Melbourne, Victoria, 3086 AustraliaLa Trobe University participates in a number of collaborative research centres and joint ventures with other research organisations, industry and government bodies. Pursuant to the Strategic Plan, the University will deepen its research capacity by supporting a number of research institutes that will provide an opportunity for a significant number of academic staff from more than one discipline area to focus their research effort on a common field of enquiry. The expectation is that all institutes will develop a strong track record of external research funding.

4 Research AvenueLabcyte provides drug discovery, genomics, assays, genetic services, and spectrometry.

62 Albert Street Preston, VIC, 3072 AustraliaAlexander & Paterson was established in 1892 by two Scottish families with the main company focus being wine distribution. This small family business soon became a company of reputable standards and performance. Taylor Ferguson & Co. Pty Ltd, established in 1898 and a forefather in the industry went on to become one of Melbourne’s greatest wine and spirit merchants. Now known as Alepat Taylor it has become one of the most influential liquor companies in Australia and excels in three sectors of the liquor industry: wholesaling, export and manufacturing .

Level 1, 18 Banksia Street, Heidelberg VIC 3084, AustraliaLabConnect is the preeminent provider of central laboratory support services for logistically and analytically complex studies. LabConnect offers clinical chemistry, DNA sequencing, nucleic acid extraction, genotyping, flow cytometry, pharmacology, and toxicology services.

Benalla, VIC, 3672 AustraliaRegional Laboratory Services offers clinical chemistry assays and animal health, agriculture, and environmental testing.

402 Swanston Street Melbourne, VIC, 3000 AustraliaThe MicroNano Research Facility (MNRF) brings together diverse and high quality multidisciplinary micro and nano technology research into a single hub. RMIT has operated cleanroom fabrication and metrology facilities for over 30 years. The new MNRF has comprehensive facilities for the design, modelling, fabrication, packaging, and characterisation of micro and nano scale devices. Nine laboratories are housed within the 1,000 square metre facility.

188 Hargraves Street Castlemaine, VIC, 3450 AustraliaGunnLab tests flexible packaging, rigid packaging and other plastic products and materials.

50 Flemington Road Parkville , Victoria , 3052 AustraliaThe mission of The Royal Children's Hospital (RCH), in conjunction with our Campus partners, is to improve the health and wellbeing of children and adolescents through leadership in healthcare, research and education. The Royal Children's Hospital is co-located with Campus partners the Murdoch Childrens Research Institute and the University of Melbourne. Together the campus partners are known as the Melbourne Children's. Led by Prof Andrew Davidson, Medical Director of the Melbourne Children's Trials Centre, research at the Melbourne Children's is a collaboration between scientists, researchers and doctors and allows research findings to be quickly put into practice. On Campus, The Royal Children's Hospital is the custodian of clinical care, The Murdoch Childrens Research Institute is the custodian of research and the University of Melbourne is the custodian of education. MCRI provides a dedicated research precinct on site and encompasses laboratory, clinical and public health focuses in its work. The University of Melbourne is the largest research University in Australia. The University has collaborated in a significant number of projects on Campus and maintains a high research profile at the Royal Children's Hospital through the research activities of the Department of Paediatrics. Our aim is to perform ground breaking translational and patient-orientated research across the breadth of paediatric disciplines. This includes: Developing innovative treatments and therapies for our patients, using our state of the art facilities Performing high quality clinical trials, both investigator and industry-led Developing novel and improved diagnostics for our patients Understanding and preventing the development and progression of childhood illnesses

Balaclava RdMacquarie University provides services for circular dichroism, fluorescence, and an optical microcharacterisation facility.

CSIRO Enquiries Locked Bag 10 Clayton South VIC 3169 AustraliaCSIRO, the Commonwealth Scientific and Industrial Research Organisation, is Australia's national science agency and one of the largest and most diverse research agencies in the world.

44 Gresswell RdMabtech develops and offers ELISpot, FluoroSpot and ELISA kits, kit components and reagents, ELISpot and FluoroSpot readers and Contract Lab Services.

Melbourne, AustraliaDishman CRAMS offers development services, kilo supply, cGMP pilot production and full scale cGMP manufacture.

Warrandyte, VIC, 3113 AustraliaScientec Research specializes in Controlled Release Drug delivery ("CRD") systems.

Victoria, AustraliaDishman CRAMS offers development services, kilo supply, cGMP pilot production and full scale cGMP manufacture.

PO Box 8051 Monash University LPO Clayton Vic 3800 AustraliaAllergenix is an Australian CRO with extensive expertise in sheep lung research and preclinical trials. Allergenix provides efficacy studies for the validation of new drug targets and drug delivery technologies. Sheep models include models for asthma, COPD, IPF, fibrosis, viral and bacterial lung infections, bronchitis, pneumonia and lung cancer. In contrast to small rodents, sheep lungs exhibit a similar structure, lobation, tidal volume and alveoli diameter, and only a slightly higher breathing rate compared to the human lung. The relative size of sheep also allows for more clinically relevant testing of delivery technologies and dose alignment. Allergenix provides in vitro, ex vivo and in vivo efficacy studies for preclinical validation of new drug targets and evaluation of emerging drug delivery technologies. Our contract services include custom study design and data interpretation by experienced team of scientists.

Monash University LPO PO Box 8051 Clayton Vic, 3800 AustraliaAllergenix is an Australian CRO with extensive expertise in sheep lung research and preclinical trials. Allergenix provides efficacy studies for the validation of new drug targets and drug delivery technologies. Sheep models include models for asthma, COPD, IPF, fibrosis, viral and bacterial lung infections, bronchitis, pneumonia and lung cancer. In contrast to small rodents, sheep lungs exhibit a similar structure, lobation, tidal volume and alveoli diameter, and only a slightly higher breathing rate compared to the human lung. The relative size of sheep also allows for more clinically relevant testing of delivery technologies and dose alignment. Allergenix provides in vitro, ex vivo and in vivo efficacy studies for preclinical validation of new drug targets and evaluation of emerging drug delivery technologies. Our contract services include custom study design and data interpretation by experienced team of scientists.

Bio21 Institute 30 Flemington Rd Parkville, Victora, 3052 AustraliaAs a pre-clinical contract research organisation focusing on small molecule drug discovery , SYNthesis offer a range of flexible collaborative relationships to our partners. Operating under a Fee for service (single compound or small library) or a Full Time Equivalent (Medicinal chemistry programs, Hit to lead and Lead Op) business model. SYNthesis has executed multiple research projects across many drug targets. We have a solid record of successful delivery with multiple clinical candidates from work conducted in our laboratories.

63 Boundary Road North Melbourne, VIC, 3051 AustraliaDTS aims to provide a comprehensive, high quality and timely service to all clients, at a competitive price. We achieve this through: 1. Training our people to continuously develop and extend their skills 2. Forming alliances and partnerships with our clients 3. Supporting industry initiatives in improving industry standards 4. Continuously monitoring and benchmarking our performance and level of service against our competitors and industry 5. A requirement for all staff to be familiar with, and prepared to implement the ideals set out in the Quality Manual 6. The commitment of management to comply with the requirements set out in the Quality Manual and ISO/IEC 17025v 7. Maintenance of NATA accreditation to the requirements of ISO/IEC 17025 for its laboratories

The Walter and Eliza Hall Institute of Medical Research 1G Royal Parade Parkville VIC 3050AGRF provides genomic services including next-generation sequencing, genotyping, gene expression analysis and structural genomics, epigenomic analysis and DNA extraction.

ASPREE National Co-ordinating and Clinical Trial Centre, Ground Floor, Burnet Building 89 Commercial Road, Melbourne 3004ASPREE’s largest sub-study has collected and stored blood and urine specimens from more than12,000 participants to date. Research using these samples may result in the identification of components (‘biomarkers’), such as proteins or genes that may help predict disease or even good health, in older people. The ASPREE Healthy Ageing Biobank is the first of its kind with a focus on older people. Because each sample is associated with a wealth of information about each participant’s health, future researchers will be able to compare biosamples from those who develop older onset disease such as dementia and cancer, versus those who do not.

305 Grattan Street Melbourne , VIC, 3000 AustraliaThe Molecular Genomics Core facility offers researchers access to state-of-the-art genomics technology platforms, providing service and expertise in conducting genomics experiments. DNA and RNA are molecules made up of a four-letter genetic code (nucleotides), a principle that is conserved across all living things. The human genome, encompassing the entire genetic code, comprises approximately three million nucleotide letters; each person has two copies, one copy inherited from each parent. Genomics technologies allow researchers to decode or count specific DNA and RNA molecules to find differences that exist between normal and diseased cells. As cancer is a genetic disease caused by mutations that are either inherited or acquired during life, genomics technologies are extremely powerful tools for discovering mutations in genes implicated in cancer. These discoveries are being translated into new diagnostic and prognostic tests, and are used to predict whether an individual will respond to a specific therapy. Such applications are enabling a more personalised treatment of cancer that increases patient survival and reduces the toxicity of cancer treatment on normal cells and tissues.

4 Redland Drive, Mitcham Victoria 3132, AustraliaMelrose Health provides safe and effective organic food and health products.

240 Plenty Road 240 Plenty Road Bundoora, VIC, 3083 AustraliavivoPharm provides proprietary preclinical oncology and immuno-oncology services, offering integrated service in different disease areas to the biotechnology and pharmaceutical industries. vivoPharm is leading in orthotopic and metastases tumor models and offers whole body imaging. Our team of highly trained specialists provides advice and optimized study design to our clients.

Level 2, 102 Victoria Street Carlton Melbourne, VIC, 3053 AustraliaThe problem we're solving Researchers struggle to find participants for research studies, leaving 80% of studies to run behind schedule and over budget. This is largly because they don’t have the support or marketing know-how to reach and communicate effectively to their desired audience. What we do We provide a platform to give researchers an online presence, connecting them with the community, and simplifying how they sign up and manage their participants. Rulo is a space where research studies are presented in a highly-engaging, and consumable way. Where they can be liked and shared with rich social media imagery and taglines, and where anyone can check their eligibility and sign up to participate.

109 Burwood Road Hawthorn VIC 3122 AustraliaAmcor is a packaging manufacturer that offers innovative and sustainable packaging solutions.

1/35 Dunlop Road Mulgrave Vic 3170 AustraliaWacker offers contract manufacturing, biologic analysis, and quality control/assurance services.

71 Yarra Street Warrandyte, Victoria 3113 AustraliaScientec Research specializes in Controlled Release Drug delivery ("CRD") systems.

3 Charltonian Close Bacchus Marsh, VIC, 3340 AustraliaData mining software for polysomnography data

Unit 10, 15 Howleys Road Notting Hill, VIC 3168 AustraliaHach Company manufactures and distributes analytical instruments and reagents used to test the quality of water and other liquids.

85 Commercial Road Melbourne, Victoria, 3004 Australia360biolabs is a contract service provider bringing together virology and immunology in a quality-assured environment. We are passionate about using cutting-edge thinking and technology to support the development of therapeutics, vaccines and diagnostics.

43 Watson Street Wallan Melbourne, VIC, 3756 Australia

3-5 Lillee Crescent Tullamarine, VIC, 3043 AustraliaAsureQuality is a commercial company 100% owned by the New Zealand government. We provide food safety and biosecurity services to the food and primary production sectors. Food Safety and Biosecurity Experts Every day our experienced team of 1700 experts works alongside customers like you, to assure the safety and quality of food being produced for millions of people worldwide. Our skilled staff and extensive accreditations enable us to audit, inspect, verify and certify food quality and management systems from the farm right to the supermarket shelf. In today’s world, ever increasing levels of trade, tourism and business travel also carry risks. Many of our customers rely on us to help them detect, control and eradicate unwanted pests and diseases.

500 Princes Highway Noble Park, Victoria 3174 AustraliaBoron Molecular specializes in supply and synthesis of fine chemicals including organoboronic acids, esters, biaryls, and cubanes.

800 Blackburn Rd Clayton, VIC 3168 AustraliaThe Australian Synchrotron is a world-class national research facility that uses accelerator technology to produce a powerful source of light – x-rays and infrared radiation – a million times brighter than the sun. The facility has nine different experimental stations, or beamlines, which harness that light so researchers can see the fundamental structure and composition of materials, on scales ranging from the atomic to the macroscopic – with a level of detail, speed and accuracy not possible in conventional laboratories. The Australian Synchrotron supports a broad range of high quality research, with applications in sectors from medicine and nanotechnology to manufacturing and mineral exploration. Our highly advanced techniques and passionate staff are contributing directly and demonstrably to scientific advances and industrial innovations with medical, social and economic benefits for all Australians.

43 Watson Street Wallan Wallan, VIC, 3756 Australia

Murdoch Childrens Research Institute The Royal Children's Hospital, Flemington Road Parkville VIC 3067 AustraliaThe Children's Cancer Centre (CCC) at the Murdoch Childrens Research Institute and The Royal Children's Hospital performs research aimed at understanding the mechanisms of childhood cancer. The CCC Tissue Bank is one of only three paediatric tumour tissue banks in Australia. As the largest centre for the treatment of paediatric cancers in Australia, the campus embodies an exciting opportunity to access rare solid and liquid tumours (such as leukaemia) from paediatric patients during the course of treatment.

76 Colemans Road Carrum Downs, VIC, 3201 AustraliaOriginating from a group of independent companies that recognize our synergies, we have combined our energies, skills and resources to deliver leading edge technologies and services to the agricultural seed industry. Our diversified research facilities, located on four continents, are guided and co-ordinated by our Innovation Council. We are focused globally, yet operate locally to deliver synergistic, customized solutions to our customers. We regard ourselves as international in the truest sense whilst staying as close to our customers as possible in everything we do.

Level 1, 530 Little Collins Street, Melbourne (CBD), VIC 3000 AUSTRALIAWholesale Group International (WGI) specializes in the supply of food technology and packaging product solutions. Through an associated business, (Total Scientific Solutions), WGI delivers nutritional, food technology and packaging consultancy to small, medium and multinational food manufacturers, and food distributors in Australia and also Japan. We specialize in the implementation of oxygen absorbers and an assortment of other absorbers (eg. CO2 releasing/ absorbing) in food products to extend shelf-life; Superior quality to traditional oxygen-absorbing satchel, reducing preservative use in food products. Our customers have specific quality assurance requirements (eg., WQA, BRC, ISO22000: HACCP, SQF2000) We can also assist in the selection of scientific testing and laboratory equipment for your food company in-house testing lab.

Level 1, 530 Little Collins Street, Melbourne (CBD), , VIC 3000 AustraliaWholesale Group International (WGI) specializes in the supply of food technology and packaging product solutions. Through an associated business, (Total Scientific Solutions), WGI delivers nutritional, food technology and packaging consultancy to small, medium and multinational food manufacturers, and food distributors in Australia and also Japan. We specialize in the implementation of oxygen absorbers and an assortment of other absorbers (eg. CO2 releasing/ absorbing) in food products to extend shelf-life; Superior quality to traditional oxygen-absorbing satchel, reducing preservative use in food products. Our customers have specific quality assurance requirements (eg., WQA, BRC, ISO22000: HACCP, SQF2000) We can also assist in the selection of scientific testing and laboratory equipment for your food company in-house testing lab.

Private bag 10 Clayton South Vic 3169 AustraliaOur national Australian Animal Health Laboratory facility is a vital part of Australia’s biosecurity infrastructure. We work closely with veterinary and human health agencies globally, as about 70 per cent of emerging infectious diseases in people originate in animals.

Private bag 10 Clayton South Vic, 3169 AustraliaOur national Australian Animal Health Laboratory facility is a vital part of Australia’s biosecurity infrastructure. We work closely with veterinary and human health agencies globally, as about 70 per cent of emerging infectious diseases in people originate in animals.

Ground Floor, 10 St Andrews Place East Melbourne, Vic, 3002 AustraliaCell Therapies provides a one-stop shop for organisations seeking cGMP manufacturing and clinical trials expertise.

Bulleen, Melbourne, Victoria, AustraliaChemical Analysis provides spectroscopy, similarity testing, impurity idenfication, bioanalytical method development, and pharmacokinetic screening.

Bulleen, VIC, 3105 AustraliaChemical Analysis provides spectroscopy, similarity testing, impurity idenfication, bioanalytical method development, and pharmacokinetic screening.

VIC AustraliaInstitute of Drug Technology Australia provides pharmaceutical contract manufacturing and clinical research services.

6 Techno Park Drive Williamstown,Victoria 3016

7-11 Rocco Drive Scoresby, VIC, 3179 AustraliaAdvanced Molecular Technologies is a contract research organisation specialising in medicinal chemistry and custom organic synthesis. The provided services involve the synthesis of target molecules, the manufacturing (larger-scale) of chemical materials, analytical chemistry, chemical method development and optimisation, drug discovery and synthetic organic research. Our manufacturing capabilities range from milligram quantities to kilogram, and consultancy (Dr. Seb. Marcuccio) is also provided. Our services extend towards the available use of laboratory-space, fume cupboards, equipment and analytical services. Analytical chemistry services include; Nuclear Magnetic Resonance (NMR), High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC), Infra-red (FT-IR), Flash Point, Optical Rotation, Dynamic Scanning Calorimetry (DSC), UV-Vis and Biotage Flash Chromatography. Expert analytical chemists are also available to interpret results, and consultation is offered upon request. We also manufacture and supply a range of niche chemical compounds including discrete PEG linkers, bioactives (including anti-virals), organoborons, fluorophores, organosilanes, nucleosides and other chemical compounds made to custom specification.

Unit 1, 40 Rocco Drive Scoresby, Victoria, 3179 AustraliaAdvanced Molecular Technologies is a contract research organisation specialising in medicinal chemistry and custom organic synthesis. The provided services involve the synthesis of target molecules, the manufacturing (larger-scale) of chemical materials, analytical chemistry, chemical method development and optimisation, drug discovery and synthetic organic research. Our manufacturing capabilities range from milligram quantities to kilogram, and consultancy (Dr. Seb. Marcuccio) is also provided. Our services extend towards the available use of laboratory-space, fume cupboards, equipment and analytical services. Analytical chemistry services include; Nuclear Magnetic Resonance (NMR), High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC), Infra-red (FT-IR), Flash Point, Optical Rotation, Dynamic Scanning Calorimetry (DSC), UV-Vis and Biotage Flash Chromatography. Expert analytical chemists are also available to interpret results, and consultation is offered upon request. We also manufacture and supply a range of niche chemical compounds including discrete PEG linkers, bioactives (including anti-virals), organoborons, fluorophores, organosilanes, nucleosides and other chemical compounds made to custom specification.

495 Blackburn Road Mt Waverley (Melbourne) VIC 3149 AustraliaInvetech provides product development, instrument development, custom automation, and contract manufacturing.

22/456 St Kilda Rd Melbourne, VIC, 3004 AustraliaThe FDA-centric Australian CRO, with global offices (Asia, UK, EU, USA). Delivering high-quality clinical research at a fraction of the cost.

VIC AustraliaNucleics offers automated DNA sequencing services, reagents, and DNA sequencing software.

103-105 Pipe Road Laverton North, VIC, 3026 AustraliaNufarm Limited is one of the world's leading crop protection and specialist seeds companies. We produce products to help farmers protect their crops against damage caused by weeds, pests and disease. With manufacturing and marketing operations based in Australia, New Zealand, Asia, Europe and the Americas, Nufarm employs more than 3,400 people, all of whom make a vital contribution to the company's reputation for quality products, innovation and first class marketing and technical support. Nufarm is listed on the Australian Stock Exchange (symbol NUF) and its head office is located at Laverton in Melbourne.

270 Ferntree Gully Road, Notting Hill VIC, 3168, AustraliaMedpace is a Full Service CRO and offers clinical development services including medical writings, biometrics, regulatory affairs and quality assurance. Also offered are Central Lab Services, Bio-Analytical, Biomarker Testing, BioSample Storage and Management, Long-term BioRepository, Core Lab Services, Imaging, and a Phase I Safety Clinic.

Department of Physiology, Faculty of Biomedical and Psychological Sciences, Monash Biomedicine Discovery Institute, Monash University Building 13F, Clayton Campus 26 Innovation Walk, Clayton Melbourne, VIC, 3800 AustraliaNeuroSolutions Ltd. was established in the UK in 2001 to provide clients with highly specialised contract electrophysiological research. Our related companies are based in Montreal, Canada (Cerebrasol Canada Ltd) and Melbourne, Australia (Pacific Discovery Services Ltd) with further laboratories in Bogor, Indonesia. The companies provide a flexible, highly skilled service with fast turnaround that meets the needs of a wide range of biopharmaceutical companies. Our large portfolio of clients, many of them repeat customers, ranging from small start-ups to multinational pharmaceutical companies provides validation of our quality, reliability, speed and discretion. How we do this; Molecular biology services Single cell rt-PCR, real time qPCR, immunohistochemistry Behavioural modelling of disease Pain models (Chung, CCI etc.), anxiety, obesity, Alzheimer’s disease In vivo electrophysiology Almost all brain regions, spinal cord, nerve fibres single fibre level, naïve and model animals In vitro slice electrophysiology Almost all brain regions, spinal cord, naïve and model animals, single/dual recordings Range of Projects; Simple fee for service: single compound contract Multiple FTE contracts: mechanism of action of a series of compounds Speciality in providing ‘proof of concept’ studies for novel chemical entities Areas; Pain; Acute, Surgical, Neuropathic, Inflammatory, Migraine, Arthritis, Diabetic Neuropathy, Chemotherapy neuropathy, Neurodegeneration; Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Huntington's Disease Psychiatry; Depression, Anxiety, Schizophrenia, Psycosis Other; Obesity, Epilepsy, Diabetes, Channelopathies, Safety Pharmacology Example Range of Models for Pain; Chronic constriction injury Spinal nerve ligation Diabetes-induced Chemotherapy-induced Fracture pain model Carrageenan Complete Freund’s adjuvant Formalin MIA UVB Surgical pain Pain Behavioural Readouts; Von Frey hair Hargreave’s Randall-Selitto Weight-bearing Paw licking, shaking, lifting Plethysmography RotaRod test Pain Electrohphysiological Assays; In vivo: Single fibre recording, spontaneous and evoked, single neurone recording from the spinal cord and brain, all naïve and modelled animals In vitro: Compound action potential recording from isolated nerves, naïve and modelled, slice patch-clamp recordings, dissociated DRG patch-clamp recordings from naïve and modelled animals Neurodegeneration Behavioural Tests; Open field: e.g. object recognition test (ORT), Y-maze, Barnes maze Operant chambers: e.g. Alternating Lever Cyclic Ratio (ALCR), delayed match-to-position (DMTP/DNMTP) Beta-amyloid induced deficits (ADDL/APP/oligomers/aggregated) α-synuclein-induced deficits Commercially available transgenic rodent models Neurodegeneration Electrophysiological Assays; In vivo: single cells – extra and intracellular recording; iontophoretic, central and parenteral drug administration Local field potentials – spontaneous and evoked, including LTP/LTD Peripheral nerves – compound and single fibre Telemetric and multi-electrode recording In vitro: whole-cell patch-clamp recordings from brain slices (current/voltage/blind/visualised) Local field potentials – spontaneous and evoked extracellular recordings from brain slices, including LTP/LTD and multi-electrode recording (MEA) Ion channel pharmacology – state-dependency, kinetics, and site of action using cultured and primary dissociated neurones, cell lines Psychiatry Behavioural Tests; Barnes maze Conflict anxiety model (high level illumination & odour) Psychiatry Electrophysiological Assays; In vivo: single unit recordings from hippocampus/ striatum/ substantia nigra/ dorsal raphe/ prefrontal cortex / brainstem Local field potential/population spike recording from hippocampus; CA1/DG/CA3, LTP, MEA In vitro: whole-cell patch-clamp recordings from brain slices (current/voltage/blind/visualised) Local field potentials – spontaneous and evoked extracellular recordings from brain slices, including LTP/LTD and multi-electrode recording (MEA) Ion channel pharmacology – state-dependency, kinetics, and site of action using cultured and primary dissociated neurones, cell lines1 Other Behavioural Tests; DIO Transgenic Mice Electrophysiological Assays; In vivo: single unit recordings from most characterised brain regions Local field potential/population spike recording from hippocampus/cortex In vitro: whole-cell patch-clamp recordings from brain slices (current/voltage/blind/visualised) Local field potentials – spontaneous and evoked extracellular recordings from brain slices Ion channel pharmacology: state-dependency, kinetics, and site of action using cultured and primary dissociated neurones, cell lines

Fitzroy, VIC, 3065 AustraliaThe Australian Tissue Engineering Centre offers toxicology, tissue growth models, stem cell services, animal models, and formulation testing.

Suite G62, 63 Turner Street Port Melbourne, Victoria 3207 AustraliaToxikos offers toxicology, regulatory affairs, and health risk assessment services for risk management decision making.

Port Melbourne, VIC, 3207 AustraliaToxikos offers toxicology, regulatory affairs, and health risk assessment services for risk management decision making.

Level 18, 101 Collins St., Melbourne VIC, 3000 AustraliaTBG Diagnostics Limited (TDL) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of molecular diagnotics kits, instruments and services. Company Structure Picture TDL is comprised of the following subsidiaries: Texas BioGene Inc. in USA, TBG Biotechnology Corp. in Taiwan, and TBG Biotechnology Inc. (Xiamen) in China. Each subsidiary is focused on different business or functions. Texas Biogene Inc. is the research center, TBG Biotechnology Corp. Taiwan, is focused on Transplant and Transfusion Genetics, and TBG Biotechnology (Xiamen) Inc. is focused on Infectious Disease, and Oncology. History Texas BioGene Inc (TBG) was founded in Texas, USA (1999), TBG is one of the leading providers of quality Human Leukocyte Antigen (HLA) Typing Kits for immune matching of bone marrow, cord blood and organ transplants. TBG has instituted a comprehensive quality control system and is an ISO13485 accredited manufacturer of medical devices including CE approved typing kits. Currently TBG has R&D, manufacturing and sales operations in the US, Taiwan and China. In 2006, Medigen Biotechnology Corp. acquired TBG for its potential in PCR diagnostics and to complement its existing drug development pipelines. To take advantage of the rapid growth in IVD market within China, Medigen Biotechnology Corp. acquired Shanghai Haoyuan in 2007 for its diagnostic distribution channels and licenses in China. By combining the strengths in TBG and Haoyuan, a new generation of Blood Screening was developed and succesfully marketed in China. In 2012, Perkin Elmer decided to acquired Shanghai Haoyuan from Medigen Biotechnology Corp. as a way to enter the Blood Screening business in China. While China is still a rapidlly growing market for IVD, TBG re-established the TBG Biotechnoloyg Inc. (Xiamen) as its new China subsidiary. The intent of this China facility is to go beyond the current scope of products and to become a major IVD leader in China. In early 2016, Progen Pharmaceiticals has decided to acquire TBG I. and rename the company to TBG Diagnostics Limited (TDL).

1st Floor Unit 9 677 Springvale Road Mulgrave , Vic, 3170 AustraliaMimotopes offers peptide synthesis and related products such antibody (polyclonal and monoclonal) services, including peptide library construction and constriction of chemically-modified and non-standard amino acids and peptides.

11 Duerdin StreetMimotopes offers peptide synthesis and related products such antibody (polyclonal and monoclonal) services, including peptide library construction and constriction of chemically-modified and non-standard amino acids and peptides.

1 Royal Parade Parkville, VIC, 3052 AustraliaThe Walter and Eliza Hall Institute is the oldest research institute in Australia and is celebrating its centenary in 2015. Our affiliation with The Royal Melbourne Hospital links research outcomes with clinical practice to accelerate discoveries for health and disease. We offer postgraduate training as the Department of Medical Biology of The University of Melbourne. Scientists undertake research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. More than 60 clinical trials based on discoveries made at the institute are underway. These include trials of vaccines for type 1 diabetes, coeliac disease and malaria, and trials of a new class of anti-cancer agents for treating patients with leukaemia. Mission Mastery of disease through discovery. Vision To be an innovative medical research institute that engages and enriches society and improves health outcomes through discovery, translation and education.

The Peter MacCallum Cancer Centre, Research department GHRattan Street Melbourne, Victoria, 3000 AustraliakConFab brings together geneticists, clinicians, surgeon, genetic counsellors, psychosocial researchers, pathologists and epidemiologists from all over Australia and New Zealand who believe the causes and consequences of familial predisposition to breast cancer can be understood only by a concerted national effort at both the basic and clinical level. In 1997, kConFab, with the help of the Family Cancer centres in Australia and New Zealand began enrolling families with a strong history of breast and breast/ovarian cancer. Genetic, epidemiological, medical and psychosocial data collected from these families by kConFab nurses and researchers are stored in a de-identified fashion in a central relational database. Biospecimens collected from family members are used to characterise germ-line mutations in predisposing genes such as BRCA1 and BRCA2. kConFab has accumulated data on more than1400 multigenerational, multicase kindreds. kConFab itself is not a research organisation in the usual sense, but rather provides a resource upon which researchers can draw. The aims of the consortium are to make data and biospecimens widely available to researchers for use in peer-reviewed, ethically-approved funded research projects on familial aspects of breast cancer. At present, kConFab is supplying biological specimens and data to more than 100 research projects world wide.

2/33-35 Smith Road Springvale, Vic 3171 Australia

2/33-35 Smith Road Springvale, , Vic , 3171 Australia

885 Mountain Highway Building 21 BAYSWATER, VIC, 3153 AustraliaChoose Crux Biolabs’ bioanalytical services for customized protein, antibody & cell assays that are reliable, timely & cost-effective. Our PC2 lab is an ISO/IEC 17025 accredited facility in Melbourne, Australia. Crux’s immunology expertise can contribute to better outcomes for clinical studies and pre-clinical R&D. Crux’s range of custom and validated services include: • ELISAs, including kit development • Multiplex cytokine & biomarker panels • PBMC processing • In vitro cell culture • Flow cytometry • Clinical project management, including logistics, kit production & laboratory manuals • Accredited partner labs with expertise in virology & microbiology, oncology & immunotherapies and clinical genomics At Crux Biolabs we understand that each study is unique. We take pride in becoming an extension of your team to deliver the best outcome for your studies.